2019
DOI: 10.3892/mmr.2019.10042
|View full text |Cite
|
Sign up to set email alerts
|

Diagnostic and prognostic value of CEP55 in clear cell renal cell carcinoma as determined by bioinformatics analysis

Abstract: Clear cell renal cell carcinoma (ccRCC) is one of the most common types of malignant adult kidney tumor. Tumor recurrence and metastasis is the primary cause of cancer-associated mortality in patients with ccRCC. Therefore, identification of efficient diagnostic and prognostic molecular markers may improve survival times. The GSE46699, GSE36895, GSE53000 and GSE53757 gene datasets were downloaded from the Gene Expression Omnibus database and contained 196 ccRCC samples and 164 adjacent normal kidney samples. B… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
11
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(12 citation statements)
references
References 60 publications
0
11
0
Order By: Relevance
“…Because ccRCC lacks obvious early symptoms, nearly 30% of patients with ccRCC have already developed to the metastatic phase by the time of diagnosis [3]. Although early and localized ccRCC can be cured by partial or radical nephrectomy, nearly 30% of patients had postoperative recurrence and metastasis, called metastatic renal cell carcinoma [4]. In recent decades, molecular targeted therapy, represented by sorafenib, has been used in metastatic renal cell carcinoma with significant objective response rates, although the clinical outcomes are still unsatisfactory because of drug resistance and adverse effects [5].…”
mentioning
confidence: 99%
“…Because ccRCC lacks obvious early symptoms, nearly 30% of patients with ccRCC have already developed to the metastatic phase by the time of diagnosis [3]. Although early and localized ccRCC can be cured by partial or radical nephrectomy, nearly 30% of patients had postoperative recurrence and metastasis, called metastatic renal cell carcinoma [4]. In recent decades, molecular targeted therapy, represented by sorafenib, has been used in metastatic renal cell carcinoma with significant objective response rates, although the clinical outcomes are still unsatisfactory because of drug resistance and adverse effects [5].…”
mentioning
confidence: 99%
“…Another level of methylation is the influence of noncoding genes on protein expression regulation. microRNAs and ncRNAs may have important roles [ 13 ]. The methylation-mediated loss of miR-34b/c can up-regulate its oncogenic target genes [ 18 , 19 ].…”
Section: Discussionmentioning
confidence: 99%
“…With the rapid development of computer technology, an increasing number of biomarkers of various tumors are identified using bioinformatics analysis, and many tumor-associated databases are established [ 13 ]. The Cancer Genome Atlas (TCGA) is a public database that includes 33 cancer types and matched clinical data [ 14 ].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Based on the section of the pathological stages, the violin diagram was generated according to the pathological stages of the cases [17].…”
Section: Gene Expression Level In Gepia (Gene Expression Pro Ling Intmentioning
confidence: 99%